Literature DB >> 28705902

Long-term risk of cancer development in adult patients with idiopathic aplastic anemia after treatment with anti-thymocyte globulin.

Joost G K van der Hem1, Liesbeth C de Wreede2, Anneke Brand1, Hendrik Veelken1, J H Frederik Falkenburg1, Constantijn J M Halkes3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28705902      PMCID： PMC5622866          DOI： 10.3324/haematol.2017.171215

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  8 in total

Review 1.  Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation.

Authors:  Simona Iacobelli
Journal:  Bone Marrow Transplant       Date:  2013-03       Impact factor: 5.483

2.  Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group.

Authors:  H J Kolb; G Socié; T Duell; M T Van Lint; A Tichelli; J F Apperley; E Nekolla; P Ljungman; N Jacobsen; M van Weel; R Wick; M Weiss; H G Prentice
Journal:  Ann Intern Med       Date:  1999-11-16       Impact factor: 25.391

3.  De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation.

Authors:  A G Sheil; A P Disney; T H Mathew; N Amiss
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

4.  Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia.

Authors:  Jean E Sanders; Ann E Woolfrey; Paul A Carpenter; Barry E Storer; Paul A Hoffmeister; H Joachim Deeg; Mary E D Flowers; Rainer F Storb
Journal:  Blood       Date:  2011-06-07       Impact factor: 22.113

5.  Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation.

Authors:  R L Paquette; N Tebyani; M Frane; P Ireland; W G Ho; R E Champlin; S D Nimer
Journal:  Blood       Date:  1995-01-01       Impact factor: 22.113

6.  Late clonal complications in severe aplastic anemia.

Authors:  A Tichelli; A Gratwohl; C Nissen; B Speck
Journal:  Leuk Lymphoma       Date:  1994-01

7.  Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.

Authors:  G Socié; M Henry-Amar; A Bacigalupo; J Hows; A Tichelli; P Ljungman; S R McCann; N Frickhofen; E Van't Veer-Korthof; E Gluckman
Journal:  N Engl J Med       Date:  1993-10-14       Impact factor: 91.245

8.  Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia.

Authors:  Norbert Frickhofen; Hermann Heimpel; Joachim P Kaltwasser; Hubert Schrezenmeier
Journal:  Blood       Date:  2002-10-10       Impact factor: 22.113
  8 in total
  1 in total

Review 1.  Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow.

Authors:  Antonio G Solimando; Carmen Palumbo; Mary Victoria Pragnell; Max Bittrich; Antonella Argentiero; Markus Krebs
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.